Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical-Pathologic Challenges in the Classification of Pulmonary Neuroendocrine Neoplasms and Targets on the Horizon for Future Clinical Practice.
Derks JL, Rijnsburger N, Hermans BCM, Moonen L, Hillen LM, von der Thüsen JH, den Bakker MA, van Suylen RJ, Speel EM, Dingemans AC. Derks JL, et al. Among authors: van suylen rj. J Thorac Oncol. 2021 Oct;16(10):1632-1646. doi: 10.1016/j.jtho.2021.05.020. Epub 2021 Jun 15. J Thorac Oncol. 2021. PMID: 34139363 Free article. Review.
Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC).
Hermans BCM, Derks JL, Thunnissen E, van Suylen RJ, den Bakker MA, Groen HJM, Smit EF, Damhuis RA, van den Broek EC, Stallinga CM, Roemen GM, Speel EJM, Dingemans AC; PALGA-group. Hermans BCM, et al. Among authors: van suylen rj. Lung Cancer. 2019 Apr;130:179-186. doi: 10.1016/j.lungcan.2019.02.022. Epub 2019 Feb 21. Lung Cancer. 2019. PMID: 30885341
DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile.
Hermans BCM, Derks JL, Thunnissen E, van Suylen RJ, den Bakker MA, Groen HJM, Smit EF, Damhuis RA, van den Broek EC; PALGA-group; Ruland A, Speel EJM, Dingemans AMC. Hermans BCM, et al. Among authors: van suylen rj. Lung Cancer. 2019 Dec;138:102-108. doi: 10.1016/j.lungcan.2019.10.010. Epub 2019 Oct 13. Lung Cancer. 2019. PMID: 31678831
Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?
Derks JL, Dingemans AC, van Suylen RJ, den Bakker MA, Damhuis RAM, van den Broek EC, Speel EJ, Thunnissen E. Derks JL, et al. Among authors: van suylen rj, van den broek ec. Histopathology. 2019 Mar;74(4):555-566. doi: 10.1111/his.13800. Epub 2019 Jan 24. Histopathology. 2019. PMID: 30485478 Free PMC article.
In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma.
Hermans BCM, Derks JL, Hillen LM, van der Baan I, van den Broek EC, von der Thüsen JH, van Suylen RJ, Atmodimedjo PN, den Toom TD, Coumans-Stallinga C, Timens W, Dinjens WNM, Dubbink HJ, Speel EM, Dingemans AC; PALGA-group. Hermans BCM, et al. Among authors: van suylen rj. Int J Cancer. 2022 Mar 1;150(5):802-815. doi: 10.1002/ijc.33853. Epub 2021 Nov 10. Int J Cancer. 2022. PMID: 34674268 Free PMC article.
Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle.
Derks JL, Speel EJ, Thunnissen E, van Suylen RJ, Buikhuisen WA, van Velthuysen ML, Dingemans AM. Derks JL, et al. Among authors: van suylen rj, van velthuysen ml. J Thorac Oncol. 2016 Mar;11(3):e35-8. doi: 10.1016/j.jtho.2015.10.013. Epub 2015 Dec 24. J Thorac Oncol. 2016. PMID: 26723240 Free article.
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
Derks JL, van Suylen RJ, Thunnissen E, den Bakker MA, Groen HJ, Smit EF, Damhuis RA, van den Broek EC, Speel EM, Dingemans AC; PALGA group. Derks JL, et al. Among authors: van suylen rj, van den broek ec. Eur Respir J. 2017 Jun 1;49(6):1601838. doi: 10.1183/13993003.01838-2016. Print 2017 Jun. Eur Respir J. 2017. PMID: 28572122 Free PMC article.
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.
Derks JL, Leblay N, Thunnissen E, van Suylen RJ, den Bakker M, Groen HJM, Smit EF, Damhuis R, van den Broek EC, Charbrier A, Foll M, McKay JD, Fernandez-Cuesta L, Speel EM, Dingemans AC; PALGA-Group. Derks JL, et al. Among authors: van suylen rj, van den broek ec. Clin Cancer Res. 2018 Jan 1;24(1):33-42. doi: 10.1158/1078-0432.CCR-17-1921. Epub 2017 Oct 24. Clin Cancer Res. 2018. PMID: 29066508
Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease.
Derks J, van Suylen RJ, Thunnissen E, den Bakker M, Groen H, Smit E, Damhuis R, van den Broek E, Speel EJ, Dingemans AC. Derks J, et al. Among authors: van suylen rj, van den broek e. Eur Respir J. 2017 Oct 26;50(4):1701658. doi: 10.1183/13993003.01658-2017. Print 2017 Oct. Eur Respir J. 2017. PMID: 29074548 Free article. No abstract available.
120 results